You are here

Award Data

For best search results, use the search terms first and then apply the filters
Reset

The Award database is continually updated throughout the year. As a result, data for FY24 is not expected to be complete until March, 2025.

Download all SBIR.gov award data either with award abstracts (290MB) or without award abstracts (65MB). A data dictionary and additional information is located on the Data Resource Page. Files are refreshed monthly.

The SBIR.gov award data files now contain the required fields to calculate award timeliness for individual awards or for an agency or branch. Additional information on calculating award timeliness is available on the Data Resource Page.

  1. Novel Antibacterial Agents That Target DNA Replication in Mycobacterium tuberculo

    SBC: Achillion Pharmaceuticals, Inc.            Topic: NIAID

    DESCRIPTION (provided by applicant): Mycobacterium tuberculosis (MTB) is probably the most ubiquitous microbial pathogen in the world today infecting one-third of the total population and causing millions of active tuberculosis (TB) cases each year. The economic costs are substantial and more than one million people die of TB infections each year. Before the arrival of antimicrobial therapy, TB wa ...

    SBIR Phase I 2010 Department of Health and Human ServicesNational Institutes of Health
  2. Turbine Inlet Gas Temperature Measurement System

    SBC: ADVANCED FUEL RESEARCH, INC.            Topic: AF083260

    The Air Force is seeking new technology that will provide the means to accurately measure and monitor turbine inlet gas temperature in gas turbine engines, particularly in advanced engines operating at very high temperatures (>3,100 degree F). In Phase I of this program, Advanced Fuel Research, Inc. demonstrated that turbine inlet gas temperature can be determined from non-intrusive measurements ...

    SBIR Phase II 2010 Department of DefenseAir Force
  3. Development of a method to multiplex ChIP-SEQ and ChIP-chip experiments

    SBC: AFFOMIX, INC.            Topic: NHGRI

    DESCRIPTION (provided by applicant): The immediate objective of our research is to generate a method that will enable researchers to multiplex Chromatin ImmunoPreciptation-Sequencing (ChIP-Seq) analysis in a single Next generation DNA sequencing run. In the to-be-developed method: i) a set of antibodies directed against specific DNA-binding proteins are uniquely bar-coded with a DNA 'ZipCode;' ii) ...

    SBIR Phase I 2010 Department of Health and Human ServicesNational Institutes of Health
  4. High-throughput screening and identification of scFv antibodies against glycosyla

    SBC: AFFOMIX, INC.            Topic: NCRR

    DESCRIPTION (provided by applicant): The specific goal of this proposal is to develop a high-throughput method to identify scFv antibodies that recognize post-translationally modified proteins. We propose to complete a proof-of-concept for a new type of affinity screening process based on emulsion, secretion, and capture, which we term ESCape . In the proposed phage ESCape method, E. coli transfo ...

    SBIR Phase I 2010 Department of Health and Human ServicesNational Institutes of Health
  5. A bifunctional antibody screening system for both phage display and yeast two-hyb

    SBC: AFFOMIX, INC.            Topic: NIAID

    DESCRIPTION (provided by applicant): This is a proposal to establish a proof-of-principle for a vector system to isolate high-affinty antibodies through selective rounds in both yeast and Escherichia coli. Antibodies have quickly become extremely useful as therapeutic medicines to treat a wide-variety of disorders. We propose to develop a means of making the discovery of immunotherapeutics faster ...

    SBIR Phase I 2010 Department of Health and Human ServicesNational Institutes of Health
  6. Synthetic nanocapsule malaria vaccines

    SBC: ARTIFICIAL CELL TECHNOLOGIES INC            Topic: NIAID

    DESCRIPTION (provided by applicant): The goal of this project is to produce novel synthetic malaria vaccines based on epitopes of the circumsporozoite (CS) protein of Plasmodium falciparum, the causative agent of human malaria. Malaria is one of the major diseases in the developing world, causing 200-500 million new infections and over 1 million deaths each year, primarily in young children in Af ...

    SBIR Phase I 2010 Department of Health and Human ServicesNational Institutes of Health
  7. Protein Microarray System for Rheumatoid Arthritis

    SBC: CIENCIA INC            Topic: NIAID

    DESCRIPTION (provided by applicant): The long-term objective of the proposed effort is to develop an autonomous clinical diagnostics system for monitoring normal and diseased immune function that occurs in the context of rheumatoid arthritis, infection, inflammation, asthma, autoimmune disease, and neoplasia. This system will be a microarray-based bioassay platform that specifically captures d ...

    SBIR Phase II 2010 Department of Health and Human ServicesNational Institutes of Health
  8. Improved Full Authority Digital Engine Control (FADEC) System

    SBC: Embedded Systems, LLC            Topic: AF093174

    The continuing demand for improving the capabilities of Full Authority Digital Engine Control (FADEC) systems while reducing their size, weight and cooling requirements has led to investigations of alternate architectures and electronic devices for the next generation of advanced propulsion systems. The feasibility of using available Silicon On Insulator (SOI) technology devices that can operate i ...

    SBIR Phase I 2010 Department of DefenseAir Force
  9. Multi-scale Physics-Based Models for High Strength Titanium Alloys Accounting for Higher-Order Microstructure Statistics.

    SBC: Global Engineering and Materials, Inc.            Topic: AF09BT29

    The goal of this proposal is to demonstrate the feasibility of new multi-scale models for linking higher order micro-structure descriptions to failure initiation and crack propagation for high cycle fatigue of high strength titanium alloys. This includes new high temperature materials such as the lightweight intermetallic titanium aluminide turbine blades to be used in the lower pressure sections ...

    STTR Phase I 2010 Department of DefenseAir Force
  10. Beta-Globin Gene Correction Using Peptide Nucleic Acids for the Treatment of Sick

    SBC: HELIX THERAPEUTICS, LLC            Topic: NHLBI

    DESCRIPTION (provided by applicant): This is a proposal to test the feasibility of using triplex-forming oligonucleotides to correct the sickle cell disease (SCD) mutation in human CD34+ cells. SCD is one of the most common human genetic diseases and is the result of one specific inherited mutation in the 2-globin gene. Hydroxyurea is currently the only FDA-approved treatment for SCD. Both support ...

    SBIR Phase I 2010 Department of Health and Human ServicesNational Institutes of Health
US Flag An Official Website of the United States Government